News Focus
News Focus
Followers 1
Posts 636
Boards Moderated 1
Alias Born 07/30/2007

Re: EZLibra post# 53745

Thursday, 07/15/2010 8:10:42 PM

Thursday, July 15, 2010 8:10:42 PM

Post# of 347009
The co didn’t say that

They may want you to think just that

What they said is: As of June 30, 2010 but Not the CC date!

http://finance.yahoo.com/news/Peregrine-Pharmaceuticals-iw-3404740157.html?x=0&.v=1

Financing Activities

In addition to Peregrine's two sources of revenue, the company increased its cash position during fiscal year 2010 by raising gross proceeds of $26.3 million in exchange for 7.5 million shares of common stock at an average price per share of $3.51 through two At Market Sales Issuance Agreements. On June 22, 2010, Peregrine entered into a new At Market Sales Issuance Agreement to sell shares of common stock for aggregate gross proceeds of up to $15 million. As of June 30, 2010, Peregrine had not sold any shares of common stock under this agreement



also please read below
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=52292980
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y